Clinical Trial Update: A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MEDI0382 for energy balance in overweight/obese individuals with type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus Type Ii
• Obesity

Drugs mentioned

• MEDI0382

Snippet

Sponsor: MedImmune LLC | Conditions: Diabetes Mellitus, Type II, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15